celecoxib and vortioxetine

celecoxib has been researched along with vortioxetine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Baune, BT; Fourrier, C; Mills, NT; Sampson, E1
Baune, BT; Clark, SR; Fourrier, C; Hori, H; Louise, J; Mills, NT; Sampson, E; Schubert, KO1
Courtet, P; Guillaume, S; Lengvenyte, A; Olie, E; Strumila, R1
Baune, BT; Fourrier, C1
Baune, BT; Clark, SR; Fourrier, C; Hohoff, C; Hori, H; Mills, NT; Sampson, E; Schubert, O; Schwarte, K1

Trials

3 trial(s) available for celecoxib and vortioxetine

ArticleYear
Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo.
    Trials, 2018, Aug-20, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Biomarkers; C-Reactive Protein; Celecoxib; Clinical Protocols; Cognition; Cyclooxygenase 2 Inhibitors; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Inflammation Mediators; Male; Middle Aged; Prospective Studies; Research Design; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Victoria; Vortioxetine; Young Adult

2018
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2021, Volume: 53

    Topics: Antidepressive Agents; Australia; C-Reactive Protein; Celecoxib; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Inflammation; Treatment Outcome; Vortioxetine

2021
Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    The Journal of clinical psychiatry, 2023, 10-04, Volume: 84, Issue:6

    Topics: C-Reactive Protein; Celecoxib; Cognition; Depressive Disorder, Major; Double-Blind Method; Humans; Treatment Outcome; Vortioxetine

2023

Other Studies

2 other study(ies) available for celecoxib and vortioxetine

ArticleYear
Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022, Volume: 55

    Topics: Antidepressive Agents; Celecoxib; Selective Serotonin Reuptake Inhibitors; Vortioxetine

2022
Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants - Author's reply.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2022, Volume: 55

    Topics: Antidepressive Agents; Celecoxib; Selective Serotonin Reuptake Inhibitors; Vortioxetine

2022